InsiderTrades.com logo
Vladimir Lenin was right…
From Porter & Company   |   Ad
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.
Including the name of the #1 company to buy.

BRTX Insider Trading

Insider Ownership Percentage: 25.50%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

BioRestorative Therapies Insider Trading History Chart

This chart shows the insider buying and selling history at BioRestorative Therapies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BioRestorative Therapies Share Price & Price History

Current Price: $1.55
Price Change: ▲ Price Increase of +0.1 (6.90%)
As of 12/20/2024 06:51 PM ET

This chart shows the closing price history over time for BRTX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
We recommended Palantir in 2021, now we’re recommending this...
From Behind the Markets   |   Ad
My research indicates there is only one investment that can meet AI's unprecedented demand for energy.
Click to get the name and ticker symbol

BioRestorative Therapies Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/27/2023Dale BroadrickMajor ShareholderBuy1,000$2.80$2,800.00306,073View SEC Filing Icon  
7/25/2023Lance AlstodtCEOBuy4,200$2.44$10,248.00184,418View SEC Filing Icon  
3/31/2023Francisco SilvaVPBuy747$3.56$2,659.32159,690View SEC Filing Icon  
2/22/2023Dale BroadrickMajor ShareholderBuy6,000$2.86$17,160.00305,073View SEC Filing Icon  
2/1/2023Lance AlstodtCEOBuy400$3.10$1,240.00187,321View SEC Filing Icon  
1/27/2023Lance AlstodtCEOBuy200$3.01$602.00186,921View SEC Filing Icon  
1/20/2023Lance AlstodtCEOBuy200$3.13$626.00186,721View SEC Filing Icon  
1/18/2023Lance AlstodtCEOBuy400$3.11$1,244.00186,521View SEC Filing Icon  
1/9/2023Lance AlstodtCEOBuy100$3.08$308.00186,121View SEC Filing Icon  
12/23/2022Lance AlstodtCEOBuy300$3.01$903.00186,021View SEC Filing Icon  
12/7/2022Lance AlstodtCEOBuy1,800$2.99$5,382.00185,721View SEC Filing Icon  
11/21/2022Francisco SilvaVPBuy943$2.62$2,470.66166,046View SEC Filing Icon  
11/18/2022Lance AlstodtCEOBuy1,000$2.88$2,880.00183,921View SEC Filing Icon  
10/11/2022Francisco SilvaVPBuy806$3.69$2,974.14164,378View SEC Filing Icon  
9/23/2022Dale BroadrickMajor ShareholderBuy300$2.83$849.00298,873View SEC Filing Icon  
9/22/2022Lance AlstodtCEOBuy200$2.92$584.00182,921View SEC Filing Icon  
8/29/2022Francisco SilvaVPBuy2,816$3.21$9,039.36163,572View SEC Filing Icon  
8/26/2022Francisco SilvaVPBuy2,600$3.35$8,710.00160,756View SEC Filing Icon  
7/12/2022Dale BroadrickMajor ShareholderBuy900$2.97$2,673.00298,373View SEC Filing Icon  
7/12/2022Lance AlstodtCEOBuy700$2.95$2,065.00182,721View SEC Filing Icon  
7/6/2022Dale BroadrickMajor ShareholderBuy100$3.38$338.00297,473View SEC Filing Icon  
6/30/2022Dale BroadrickMajor ShareholderBuy1,900$3.08$5,852.00297,373View SEC Filing Icon  
6/30/2022Lance AlstodtCEOBuy1,100$3.10$3,410.00182,021View SEC Filing Icon  
6/21/2022Dale BroadrickMajor ShareholderBuy100$3.68$368.00295,473View SEC Filing Icon  
6/17/2022Dale BroadrickMajor ShareholderBuy600$3.80$2,280.00295,373View SEC Filing Icon  
6/15/2022Dale BroadrickMajor ShareholderBuy1,200$3.72$4,464.00292,773View SEC Filing Icon  
6/15/2022Lance AlstodtCEOBuy700$3.68$2,576.00180,321View SEC Filing Icon  
6/15/2022Robert Eugene KristalCFOBuy194$3.61$700.347,994View SEC Filing Icon  
6/13/2022Dale BroadrickMajor ShareholderBuy1,300$3.92$5,096.00291,573View SEC Filing Icon  
6/13/2022Lance AlstodtCEOBuy200$3.95$790.00179,121View SEC Filing Icon  
6/10/2022Dale BroadrickMajor ShareholderBuy600$4.23$2,538.00290,273View SEC Filing Icon  
6/8/2022Dale BroadrickMajor ShareholderBuy2,400$4.33$10,392.00288,673View SEC Filing Icon  
6/8/2022Lance AlstodtCEOBuy100$4.28$428.00178,921View SEC Filing Icon  
6/7/2022Robert Eugene KristalCFOBuy200$4.56$912.007,800View SEC Filing Icon  
6/6/2022Dale BroadrickMajor ShareholderBuy3,000$4.93$14,790.00282,673View SEC Filing Icon  
6/2/2022Dale BroadrickMajor ShareholderBuy1,000$4.69$4,690.00278,473View SEC Filing Icon  
6/1/2022Lance AlstodtCEOBuy200$4.60$920.00178,821View SEC Filing Icon  
5/26/2022Dale BroadrickMajor ShareholderBuy4,950$3.51$17,374.50259,303View SEC Filing Icon  
5/26/2022Lance AlstodtCEOBuy2,700$3.52$9,504.00178,621View SEC Filing Icon  
5/2/2022Lance AlstodtCEOBuy400$3.95$1,580.00175,921View SEC Filing Icon  
4/8/2022Robert Eugene KristalCFOBuy7,600$5.71$43,396.007,600View SEC Filing Icon  
4/5/2022Dale BroadrickMajor ShareholderBuy46,000$5.71$262,660.00254,353View SEC Filing Icon  
3/31/2022Dale BroadrickMajor ShareholderBuy10,700$4.72$50,504.00View SEC Filing Icon  
3/29/2022Dale BroadrickMajor ShareholderBuy5,000$5.12$25,600.00View SEC Filing Icon  
3/21/2022Dale BroadrickMajor ShareholderBuy10,000$4.35$43,500.00View SEC Filing Icon  
3/9/2022Dale BroadrickMajor ShareholderBuy11,875$4.00$47,500.00View SEC Filing Icon  
3/7/2022Dale BroadrickMajor ShareholderBuy24,392$4.43$108,056.56View SEC Filing Icon  
3/3/2022Dale BroadrickMajor ShareholderBuy47,648$5.47$260,634.56View SEC Filing Icon  
3/1/2022Dale BroadrickMajor ShareholderBuy2,270$5.55$12,598.50View SEC Filing Icon  
1/24/2022Lance AlstodtCEOBuy1,470$3.40$4,998.00View SEC Filing Icon  
1/5/2022Lance AlstodtCEOBuy2,000$3.85$7,700.00View SEC Filing Icon  
See Full Table
AI breakthrough about to upend industry
From Porter & Company   |   Ad
Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.
I urge you to watch it now.

SEC Filings (Institutional Ownership Changes) for BioRestorative Therapies (OTCMKTS:BRTX)

69.38% of BioRestorative Therapies stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

BioRestorative Therapies Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/8/2023Cambridge Investment Research Advisors Inc.28,050$77K0.0%+22.0%0.768%Search for SEC Filing on Google Icon
5/12/2022Ayrton Capital LLC77,762$0.41M0.5%-31.0%2.144%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
BioRestorative Therapies logo
BioRestorative Therapies, Inc. engages in the development of therapeutic products and medical therapies using cell and tissue protocols. Its programs provide quality of care for chronic back pain caused by disc degeneration and metabolic disorders, including obesity and diabetes. The company's initial investigational therapeutic product being called BRTX-100 focuses on treating damage by an autologous stem cell product that uses own stem cells that are harvested, cultured, and then injected directly into the affected disc to start the repair process. BioRestorative Therapies was founded on June 13, 1997 and is headquartered in Melville, NY.
Read More on BioRestorative Therapies

Today's Range

Now: $1.55
Low: $1.42
High: $1.55

50 Day Range

MA: $1.54
Low: $1.38
High: $1.73

52 Week Range

Now: $1.55
Low: $1.03
High: $3.67

Volume

16,050 shs

Average Volume

699,377 shs

Market Capitalization

$10.73 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

62.52

Who are the company insiders with the largest holdings of BioRestorative Therapies?

BioRestorative Therapies' top insider investors include:
  1. Dale Broadrick (Major Shareholder)
  2. Lance Alstodt (CEO)
  3. Francisco Silva (VP)
Learn More about top insider investors at BioRestorative Therapies.
Vladimir Lenin was right…
From Porter & Company   |   Ad
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.
Including the name of the #1 company to buy.